| Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra bmj 371, 2020 | 803 | 2020 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. RC Group. Lancet 400 (10349), 359-368., 2022 | 215 | 2022 |
| IAP Textbook of pediatrics A Parthasarathy, PSN Menon, MKC Nair Jaypee Brothers Medical Publishers, 2019 | 163 | 2019 |
| Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study G Kumar, A Mukherjee, RK Sharma, GR Menon, D Sahu, N Wig, S Panda, ... Indian Journal of Medical Research 153 (5-6), 619-628, 2021 | 80 | 2021 |
| Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis S Singh, A Singh, S Prajapati, SK Kabra, R Lodha, A Mukherjee, V Singh, ... BMC microbiology 15, 1-10, 2015 | 74 | 2015 |
| Etiology of acute respiratory infections in infants: a prospective birth cohort study P Kumar, GR Medigeshi, VS Mishra, M Islam, S Randev, A Mukherjee, ... The Pediatric infectious disease journal 36 (1), 25-30, 2017 | 53 | 2017 |
| Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children A Mukherjee, T Velpandian, M Singla, K Kanhiya, SK Kabra, R Lodha BMC Infectious Diseases 15, 1-11, 2015 | 53 | 2015 |
| SARS-CoV-2 re-infection: development of an epidemiological definition from India A Mukherjee, T Anand, A Agarwal, H Singh, P Chatterjee, J Narayan, ... Epidemiology & Infection 149, e82, 2021 | 49 | 2021 |
| Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis AB Troxel, E Petkova, K Goldfeld, M Liu, T Tarpey, Y Wu, D Wu, A Agarwal, ... JAMA Network Open 5 (1), e2147331-e2147331, 2022 | 45 | 2022 |
| Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum S Jenum, S Dhanasekaran, R Lodha, A Mukherjee, D Kumar Saini, ... Scientific reports 6 (1), 18520, 2016 | 45 | 2016 |
| Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children JE Gjøen, S Jenum, D Sivakumaran, A Mukherjee, R Macaden, SK Kabra, ... Scientific reports 7 (1), 5839, 2017 | 44 | 2017 |
| Aeroallergen sensitization in childhood asthmatics in northern India D Raj, R Lodha, A Pandey, A Mukherjee, A Agrawal, SK Kabra, ... Indian pediatrics 50, 1113-1118, 2013 | 42 | 2013 |
| Ambulatory gastric lavages provide better yields of Mycobacterium tuberculosis than induced sputum in children with intrathoracic tuberculosis A Mukherjee, S Singh, R Lodha, V Singh, AC Hesseling, HMS Grewal, ... The Pediatric infectious disease journal 32 (12), 1313-1317, 2013 | 41 | 2013 |
| Quality of life and psychosocial functioning of HIV infected children S Das, A Mukherjee, R Lodha, M Vatsa The Indian Journal of Pediatrics 77, 633-637, 2010 | 41 | 2010 |
| Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial R Lodha, A Mukherjee, V Singh, S Singh, H Friis, D Faurholt-Jepsen, ... The American journal of clinical nutrition 100 (5), 1287-1297, 2014 | 39 | 2014 |
| Vitamin D levels in Indian children with intrathoracic tuberculosis D Khandelwal, N Gupta, A Mukherjee, R Lodha, V Singh, HMS Grewal, ... Indian Journal of Medical Research 140 (4), 531-537, 2014 | 35 | 2014 |
| Does neutralization of gastric aspirates from children with suspected intrathoracic tuberculosis affect mycobacterial yields on MGIT culture? D Parashar, SK Kabra, R Lodha, V Singh, A Mukherjee, T Arya, ... Journal of Clinical Microbiology 51 (6), 1753-1756, 2013 | 32 | 2013 |
| Development and validation of a treatment benefit index to identify hospitalized patients with COVID-19 who may benefit from convalescent plasma H Park, T Tarpey, M Liu, K Goldfeld, Y Wu, D Wu, Y Li, J Zhang, ... JAMA network open 5 (1), e2147375-e2147375, 2022 | 31 | 2022 |
| PLACID Trial Collaborators: Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID … A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra Bmj 371, m3939, 2020 | 31 | 2020 |
| Dyslipidemia in HIV infected children receiving highly active antiretroviral therapy A Mandal, A Mukherjee, R Lakshmy, SK Kabra, R Lodha The Indian Journal of Pediatrics 83, 226-231, 2016 | 30 | 2016 |
Rakesh LodhaAll India Institute of Medical SciencesVerified email at aiims.ac.in
